We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current NKTX market cap is 370.99M. The company's latest EPS is USD -2.3944 and P/E is -3.09.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -30.26M | -34.98M | -34.31M | -36.86M | -29.29M |
| Net Income | -28.35M | -32.58M | -30.82M | -33.29M | -25.65M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 115k | 0 | 0 | 0 | 0 |
| Operating Income | -22.35M | -51.51M | -86.43M | -118.96M | -131.65M |
| Net Income | -21.08M | -91.36M | -86.08M | -113.84M | -117.5M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 503.8M | 472.94M | 458.17M | 429.04M | 405.86M |
| Total Liabilities | 104.54M | 100.73M | 111.52M | 111.06M | 109.05M |
| Total Equity | 399.26M | 372.21M | 346.65M | 317.98M | 296.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 48.41M | 337.65M | 273.9M | 472.94M | 378.89M |
| Total Liabilities | 14.08M | 16.43M | 22.94M | 100.73M | 105.6M |
| Total Equity | -25.48M | 321.22M | 250.97M | 372.21M | 273.29M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -49.67M | -57M | -20.76M | -42.53M | -62.81M |
| Investing | -189.44M | -184.69M | 36.93M | 33.76M | 63.18M |
| Financing | 218.59M | 219.01M | 1,000 | 396k | 396k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.37M | -43.51M | -67.93M | -57M | -86.16M |
| Investing | -18.3M | -210.08M | 32.53M | -184.69M | 79.02M |
| Financing | 49.58M | 329.82M | 1.2M | 219.01M | 691k |
| Market Cap | 370.99M |
| Price to Earnings Ratio | -3.09 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 11.7 |
| Price to Book Ratio | 1.33 |
| Dividend Yield | - |
| Shares Outstanding | 49.07M |
| Average Volume (1 week) | 914.67k |
| Average Volume (1 Month) | 936.29k |
| 52 Week Change | 50.90% |
| 52 Week High | 16.24 |
| 52 Week Low | 1.28 |
| Spread (Intraday) | 1.12 (13.27%) |
| Company Name | Nkarta Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
